Clinical Trial Update: Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial evaluating montelukast as prophylaxis for upper respiratory tract infections in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Upper Respiratory Tract Infection | Phase 3 | Status: UNKNOWN